 |
|
"Combination" Lyme Disease Vaccine Proteins Patented
April 10, 2007Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease.
The genetically engineered proteins combine pieces of two proteins that are normally present on the surface of the bacterium that causes Lyme disease, but at different parts of the organism's life cycle. "Combining pieces of these two proteins into one chimeric protein should trigger a 'one-two-punch' immune response more capable of fending off the bacterium than either protein alone," says Brookhaven biologist John Dunn, a researcher on the BNL Lyme disease team. "These chimeric proteins could also be used as diagnostic reagents that distinguish disease-causing strains of bacteria from relatively harmless ones, and help assess the severity of an infection," Dunn said.
Lyme disease is the most common vector-borne disease in the U.S., causing approximately 25,000 new cases each year — a rate that is expected to increase by at least a third from 2002 to 2012, according to a new study. Early symptoms of the disease, which is spread by the bite of an infected deer tick, include a bull's-eye rash at the site of the bite and flu-like symptoms. If not promptly treated with antibiotics, it can lead to more serious symptoms, including joint and neurological complications.
Scientists have been working on vaccines based on the structures of proteins found on the outer surface of Borrelia burgdoferi, the bacterium that causes Lyme disease. Dunn and colleagues deciphered the atomic level structures of these proteins, known as outer surface proteins A and C (OspA and OspC), at the National Synchrotron Light Source (NSLS) at Brookhaven Lab. The OspA protein, which was used to make the original vaccine against Lyme disease, is only present in the bacteria while they are in the cold-blooded deer tick's stomach, and not in the host. After the tick bites a warm-blooded mammalian host, the injected bacteria produce OspC on their surface.
With the aim of developing a vaccine that would trigger an immune response against both these life cycle stages, Dunn's team used methods of recombinant DNA to create new proteins that combine the most immunogenic portions of OspA and OspC — that is, the regions of the two proteins that are most likely to trigger an immune response.
The researchers have demonstrated that the new combination proteins retain the ability to trigger an immune response to at least one or both of the antigens, and can trigger the production of antibodies that inhibit growth of and/or kill Borrelia bacteria in laboratory cultures. They've also shown that the chimeric proteins can be mass-produced in E. coli bacteria, a common laboratory technique for making proteins, and easily purified for possible use in vaccines or diagnostic assays.
"This could lead to a vaccine that is effective at different stages of the organism's life cycle," said Dunn. Moreover, by incorporating unique protein fragments from various pathogenic families of Borrelia, these chimeric proteins could be used to distinguish clinically important exposure to disease-causing Borrelia from exposures to other non-pathogenic families of Borrelia.
The patent covers the development of the chimeric proteins themselves, the nucleic acids (genetic material) used to generate the proteins, the methods used to make the proteins, the methods used to deliver either the proteins or nucleic acids, the use of the proteins in diagnostic assays or kits, and their use in animals and humans as vaccines against Lyme disease.
This research was funded by the Office of Biological and Environmental Research within the U.S. Department of Energy's Office of Science and by the National Institutes of Health.
Brookhaven National Laboratory
Scientists have been working on vaccines based on the structures of proteins found on the outer surface of Borrelia burgdoferi, the bacterium that causes Lyme disease. Dunn and colleagues deciphered the atomic level structures of these proteins, known as outer surface proteins A and C (OspA and OspC), at the National Synchrotron Light Source (NSLS) at Brookhaven Lab. The OspA protein, which was used to make the original vaccine against Lyme disease, is only present in the bacteria while they are in the cold-blooded deer tick's stomach, and not in the host. After the tick bites a warm-blooded mammalian host, the injected bacteria produce OspC on their surface.
With the aim of developing a vaccine that would trigger an immune response against both these life cycle stages, Dunn's team used methods of recombinant DNA to create new proteins that combine the most immunogenic portions of OspA and OspC — that is, the regions of the two proteins that are most likely to trigger an immune response.
The researchers have demonstrated that the new combination proteins retain the ability to trigger an immune response to at least one or both of the antigens, and can trigger the production of antibodies that inhibit growth of and/or kill Borrelia bacteria in laboratory cultures. They've also shown that the chimeric proteins can be mass-produced in E. coli bacteria, a common laboratory technique for making proteins, and easily purified for possible use in vaccines or diagnostic assays.
"This could lead to a vaccine that is effective at different stages of the organism's life cycle," said Dunn. Moreover, by incorporating unique protein fragments from various pathogenic families of Borrelia, these chimeric proteins could be used to distinguish clinically important exposure to disease-causing Borrelia from exposures to other non-pathogenic families of Borrelia.
The patent covers the development of the chimeric proteins themselves, the nucleic acids (genetic material) used to generate the proteins, the methods used to make the proteins, the methods used to deliver either the proteins or nucleic acids, the use of the proteins in diagnostic assays or kits, and their use in animals and humans as vaccines against Lyme disease.
This research was funded by the Office of Biological and Environmental Research within the U.S. Department of Energy's Office of Science and by the National Institutes of Health.
Brookhaven National Laboratory
Lyme Disease News and Current Lyme Disease Events RSSDiversity among bird populations found to reduce threat of West Nile virus
A biologist and undergraduate student have discovered that what's good for an area's bird population is also good for people living nearby.
Researchers track Lyme disease spirochetes
Microbiologists at the University of Calgary have demonstrated the first direct visualization of the dissemination of Borrelia burgdorferi, the bacterium that causes Lyme disease.
Drug prevents dangerous tick diseases
Lyme disease is the blight of countryside users but it may be prevented with a single injection, according to research published in the Journal of Medical Microbiology.
University of Pennsylvania Study Reveals Inconspicuous Hosts in the Lyme Disease Epidemic
A study led by a University of Pennsylvania biologist in the tick-infested woods of the Hudson Valley is challenging the widely held belief that mice are the main animal reservoir for Lyme disease in the U.S.
First placebo-controlled study of cognitive impairment due to chronic Lyme disease
Findings from the first placebo-controlled study of chronic cognitive impairment after treated Lyme disease (also known as chronic Lyme encephalopathy) demonstrate that patients report moderate cognitive impairment, physical dysfunction comparable to patients with congestive heart failure, and fatigue comparable to patients with multiple sclerosis.
Water, air and soil pollution causes 40 percent of deaths worldwide, Cornell research survey finds
About 40 percent of deaths worldwide are caused by water, air and soil pollution, concludes a Cornell researcher. Such environmental degradation, coupled with the growth in world population, are major causes behind the rapid increase in human diseases, which the World Health Organization has recently reported.
Animal testing alternative has ticks trembling at the knees
The thousands of test animals currently required to evaluate new pesticides could be replaced by tricking ticks into setting up home on a faux cow hide.
LIAI scientists identify immune system trigger for fighting Lyme disease
Researchers at the La Jolla Institute for Allergy & Immunology (LIAI) today announced an important finding on Lyme disease that could eventually lead to the development of a new vaccine to prevent this tick-borne disorder.
Infectious disease experts offer advice to prevent and treat lyme disease
It's tick season, but gardeners, hikers, and others enjoying the great outdoors shouldn't let concerns about Lyme disease keep them inside. A few tips to keep ticks away, and some advice from infectious diseases doctors about Lyme disease, should help you enjoy the spring and summer weather.
A new view on Lyme disease: Rodents hold the key to annual risk
In the United States, Lyme disease incidence has skyrocketed from 497 cases reported in 1982 (the first year national statistics were collected) to a record 23,763 in 2002.
More Lyme Disease News Articles
 | Cure Unknown: Inside the Lyme Epidemic by Pamela Weintraub A groundbreaking and controversial narrative investigation into the science, history, medical politics, and patient experience of Lyme disease told by a science journalist whose entire family contracted the disease.Pamela Weintraub paints a nuanced picture of the intense controversy and crippling uncertainty surrounding Lyme disease and sheds light on one of the angriest medical disputes raging... |
 | Healing Lyme: Natural Healing And Prevention of Lyme Borreliosis And Its Coinfections by Stephen Harrod Buhner Despite Centers for Disease Control estimates that only 20,000 new Lyme disease infections occur each year, the true figure, as Harvard medical school researchers have found, nearly approaches 200,000. Symptoms run from mild lethargy to severe arthritis to incapacitating mental dysfunction. And despite medical pronouncements to the contrary, extensive research has found that tests for the disease... |
 | The Lyme Disease Solution by Kenneth B. Singleton Lyme disease has become the fastest-growing infectious disease transmitted by ticks (or other vectors) in the United States, but still remains a condition that is frequently misunderstood, overlooked, and misdiagnosed. Written by a leading practitioner of Lyme-aware medicine, this comprehensive guide will reveal to you the facts about this very serious disease - symptoms of which can mimic... |
 | The Top 10 Lyme Disease Treatments: Defeat Lyme Disease with the Best of Conventional and Alternative Medicine by Bryan Rosner New Lyme Disease treatments are desperately needed. This book provides them. The book identifies ten cutting-edge conventional and alternative treatments and gives practical guidance on integrating them into a comprehensive treatment plan that maximizes therapeutic benefit while minimizing side effects. On the pages of this book you will find the most accurate, current Lyme Disease information... |
 | Beating Lyme: Understanding and Treating This Complex and Often Misdiagnosed Disease by Constance A. Bean, Lesley Ann Fein More than 30 years after it was first diagnosed, Lyme disease remains one of our most misunderstood illnesses. This frequently misdiagnosed infection is spreading at an alarming rate and, if not treated early, can cause debilitating symptoms. More than 1.7 million people in the United States, and others in Europe and Asia, currently have Lyme and are unaware or can't find the right treatment.... |
 | Peripheral Neuropathy: When the Numbness, Weakness, and Pain Won't Stop (American Academy of Neurology) by Norman Latov Peripheral neuropathy, the variety of conditions that result when the nerves that connect to the brain and spinal cord are damaged or diseased, is commonly associated with diseases such as diabetes, HIV, alcoholism, and lupus. Although widespread — it affects 10–20 million people in the United States — information about the condition has been difficult to obtain. This essential... |
 | When Antibiotics Fail: Lyme Disease and Rife Machines, with Critical Evaluation of Leading Alternative Therapies by Bryan Rosner There are enough books and websites about what Lyme Disease is and which ticks carry it. But there is very little useful information for people who actually have a case of Lyme Disease that is not responding to conventional antibiotic treatment. Lyme Disease sufferers need to know how to get better, not how to identify a tick. This book is about how experimental frequency devices known as... |
 | The Lyme Disease Survival Guide: Physical, Lifestyle, and Emotional Strategies for Healing by Connie Strasheim The Lyme Disease Survival Guide, written by health care journalist Connie Strasheim, offers not only a new perspective on Lyme disease diagnosis and treatment, but also much-needed wisdom for dealing with Lyme disease on an emotional, physical, and lifestyle level. Author Connie Strasheim combines sharp knowledge of the nuts and bolts of a Lyme disease treatment campaign with a witty style and... |
| Lyme Disease and Modern Chinese Medicine by Dr. QingCai Zhang, Yale Zhang Lyme disease is the fastest growing infectious disease and it is now epidemical in the Northeast, Middle West, and Northwest regions of the United States. The number of reported cases has doubled in last decade and the infection scale has become larger than HIV. Aside from hepatitis C, Lyme Disease may be the second largest infectious disease in this country. Worldwide, it is also rapidly... | |
 | 2008 Lyme Disease Annual Report: A Yearly Update for Doctors and Patients by Bryan Rosner Every year, newsworthy events throughout the Lyme Disease community will be chronicled in our Annual Report. This issue contains exciting and provocative topics including: The neuropsychiatric manifestations of Lyme Disease The debate surrounding the chronic form of the infection The supplement of the year: glyconutrients Updates on patient activism and physician criticism News from Bryan... |
| © 2008 BrightSurf.com |